Patient with severe acute respiratory syndrome coronavirus 2 nosocomial infection undergoing superselective intra‐arterial chemoradiation therapy for maxillary gingival carcinoma: A case report

Abstract

AbstractBackgroundThe ongoing coronavirus disease 2019 (COVID‐19) pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection, has changed cancer treatment. However, specific guidelines for patients with oral cancer and SARS‐CoV‐2 infection, especially for chemoradiation therapy (CRT), are lacking.Case PresentationWe report a case of a woman with oral squamous cell carcinoma diagnosed with SARS‐CoV‐2 nosocomial infection, although she had no COVID‐19 symptoms, while undergoing superselective intra‐arterial CRT. She received sotrovimab while continuing CRT and achieved a complete response.ConclusionThe general condition of the patient and the CRT regimen characteristics should be considered in the treatment of patients with COVID‐19 and cancer.